Virtu Financial’s Novavax NVAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-97,148
Closed -$791K 2044
2026
Q1
$791K Buy
+97,148
New +$881K 0.03% 398
2025
Q1
Sell
-29,830
Closed -$240K 1826
2024
Q4
$240K Buy
+29,830
New +$288K 0.01% 805
2022
Q1
Sell
-6,705
Closed -$959K 1857
2021
Q4
$959K Sell
6,705
-9,961
-60% -$1.71M 0.1% 199
2021
Q3
$3.46M Buy
+16,666
New +$3.67M 0.3% 37
2021
Q2
Sell
-20,089
Closed -$3.64M 1891
2021
Q1
$3.64M Buy
+20,089
New +$4M 0.26% 39
2020
Q3
Sell
-66,705
Closed -$5.56M 1363
2020
Q2
$5.56M Buy
+66,705
New +$2.55M 0.64% 22
2019
Q4
$170K Sell
42,825
-7,550
-15% -$32.7K 0.02% 980
2019
Q3
$253K Sell
50,375
-20,694
-29% -$113K 0.02% 843
2019
Q2
$417K Buy
71,069
+66,923
+1,614% +$527K 0.02% 616
2019
Q1
$46K Buy
4,146
+300
+8% +$9.47K ﹤0.01% 1223
2018
Q4
$142K Buy
3,846
+1,611
+72% +$62.4K 0.01% 1053
2018
Q3
$84K Sell
2,235
-1,981
-47% -$55.8K 0.01% 1228
2018
Q2
$113K Buy
+4,216
New +$143K 0.01% 1627
2018
Q1
Sell
-56,242
Closed -$1.4M 2393
2017
Q4
$1.4M Buy
56,242
+55,738
+11,059% +$1.36M 0.07% 307
2017
Q3
$11K Buy
+504
New +$11.3K ﹤0.01% 2406
2016
Q1
Sell
-708
Closed -$119K 479
2015
Q4
$119K Buy
+708
New +$109K 0.02% 354
2015
Q3
Sell
-1,920
Closed -$428K 377
2015
Q2
$428K Buy
+1,920
New +$337K 0.04% 225

Other funds holding NVAX

Virtu Financial's NVAX Position: Q2 2026 in Review

Virtu Financial sold out of Novavax (NVAX) in Q2 2026, closing a stake of 97,148 shares — an estimated $791K sold.

Virtu Financial first reported a position in NVAX in Q2 2015 and held it in 17 quarters. The position peaked at $5.56M in Q2 2020. 266 funds tracked by Wall St. Rank hold NVAX as of Q2 2026.

  • Virtu Financial reported no remaining Novavax position as of Q2 2026 after selling out during the quarter.
  • Virtu Financial sold 97,148 Novavax shares in Q2 2026, an estimated $791K.
  • Virtu Financial first reported a position in Novavax in Q2 2015 and held it in 17 quarters.
  • Virtu Financial's Novavax position peaked at $5.56M in Q2 2020.
  • 266 funds tracked by Wall St. Rank held Novavax as of Q2 2026.

Based on Virtu Financial's 13F filing for Q2 2026, filed 13 Aug 2026.